In this phase @ , double-blind trial ( NCT@ ) , @ healthy male volunteers were randomized @:@:@ to receive a single @mgkg ( -@ ) intravenous dose of PF-@ , trastuzumab-EU , or trastuzumab-US , and evaluated for @ days .